Intellia Therapeutics (38I.F) Q2 2025 Earnings

8MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.39
-1.25
-1.12
-0.98

Details

Expected EPS
-1.1393304607999999
Actual EPS
-0.979847
Surprise EPS
0.16
Surprise Percent
+14%

Description

Intellia Therapeutics (38I.F) has reported earnings of -0.979847 per share for Q2 2025.

0 Comments

Share your thoughts